Dierks+Company
Dierks+Company is a Berlin-based legal and strategy consultancy that advises healthcare and life sciences enterprises across pharmaceuticals, medical devices, diagnostics, digital health, hospitals, payers, and regulators on regulatory, market access, and health policy matters in Germany and the EU.
- Company typePrivate
- Founded2018
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Dierks+Company does
Dierks+Company is a Berlin-based legal and strategy consulting firm exclusively focused on the healthcare and life sciences sector. Founded in 2018 by Prof. Dr. med. Dr. iur. Christian Dierks, a physician-lawyer and professor for health systems research at Charité Berlin, and Juliana Dierks, a CPA with prior senior pharmaceutical leadership at Shire, Bayer, and Medco Health Solutions, the firm operates through three cooperating German limited liability entities — Operations GmbH, Consulting GmbH, and Rechtsanwaltsgesellschaft mbH — that together deliver a combined legal advisory and strategic consultancy offering.
The firm's core services span five practice areas: Health Data (cloud and GDPR compliance for healthcare), Market Access + HTA (AMNOG, EU-HTA, reimbursement), Research + Development (regulatory and IP), Health Policy + System Transformation, and Innovative Care Solutions (DiGA, telemedicine, novel care models). It complements these services with three proprietary stakeholder-convening initiatives — the EHDS Coalition, the TeleHealth Coalition, and change4RARE — plus a physical innovation venue, the HELIX HUB, which has hosted political coalition talks. No proprietary software, API, or technology product is offered; the firm's value is expertise-driven rather than platform-driven.
Revenue is generated on a professional services basis, primarily through bespoke legal and strategic consulting engagements for enterprise clients — described as "industry innovation leaders" across pharmaceuticals, medical devices, IVD, digital health, hospitals, payers, legislators, research institutes, telehealth, pharmacies, home care, and healthcare-focused investors in the DACH region. The firm also sells at least one packaged product, a Quick Check cloud compliance advisory priced at a fixed €12,500 (excluding VAT). Distribution is direct and senior-led, supported by a thought-leadership engine (publications, media commentary in FAZ, Ärztezeitung, Tagesspiegel Background, podcasts, virtual round tables, and earned PR) and has earned JUVE and Best Lawyers recognition in 2021.
Dierks+Company firmographics
Firmographics- Name
- Dierks+Company
- Legal name
- Dierks+Company Operations GmbH, Dierks+Company Consulting GmbH, and Dierks+Company Rechtsanwaltsgesellschaft mbH
- Website
- https://dierks.company
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dierks+Company is a Berlin-based legal and strategy consultancy that advises healthcare and life sciences enterprises across pharmaceuticals, medical devices, diagnostics, digital health, hospitals, payers, and regulators on regulatory, market access, and health policy matters in Germany and the EU.
- Ownership category
- akta.pro rank
Where Dierks+Company is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Dierks+Company business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Revenue model
- Legal and Strategy Consulting Services: Dierks+Company generates revenue through fees for legal and strategy consulting services in healthcare and life sciences. Services are billed on a professional services basis, likely hourly or project-based. The firm also publishes expert opinions, legal memos, and reports for clients and the public, which serve as client acquisition and thought leadership tools. Whitepaper and digital content downloads are offered at no direct charge (paid with personal data). A Quick Check cloud compliance service is priced at a fixed fee of €12,500 (excluding VAT).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Quick Check – Cloud Compliance Advisory |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels9 records
Dierks+Company product offering
Product offeringCore offering
Dierks+Company provides legal and strategy consulting services to healthcare and life sciences clients across Germany and Europe. The firm operates across five core practice areas: Health Data, Market Access + HTA, Research + Development, Health Policy + System Transformation, and Innovative Care Solutions. Services are delivered by senior experts combining legal counsel (through Rechtsanwaltsgesellschaft mbH) and strategic consulting (through Consulting GmbH) for pharmaceutical, medical device, IVD, digital health, hospital, payer, and legislative clients.
Product overview
Dierks+Company is a legal and strategy consulting firm for healthcare and life sciences, offering advisory services across five core practice areas: Health Data, Market Access + HTA, Research + Development, Health Policy + System Transformation, and Innovative Care Solutions. The firm combines legal expertise with strategic consulting to help clients navigate regulatory challenges, achieve market access, and drive healthcare innovation. They operate collaborative initiatives including the EHDS Coalition and TeleHealth Coalition, and lead the change4RARE initiative focused on rare disease policy. Dierks+Company is not a software product company but rather a professional services firm providing expert advisory, strategic guidance, and regulatory consulting to the healthcare and life sciences industry.
Differentiator
Problem solved
Functional benefit
Brands
- HELIX HUB: A physical/location-based innovation hub referenced on the website, hosted exploratory talks between SPD, FDP and the Greens during coalition negotiations.
- EHDS Coalition
- TeleHealth Coalition
- change4RARE
Products and services
- Health Data Services Advisory services on health data regulations, including cloud-based health data solutions, GDPR compliance for healthcare data processing, and guidance on data processor requirements. Targets healthcare and life sciences organizations handling health data in Germany and the EU.
- Market Access + HTA Strategic consulting for market access and Health Technology Assessment procedures, helping pharmaceutical, medical device, and digital health companies navigate regulatory approval and reimbursement pathways in European markets, including AMNOG and EU-HTA processes.
- Research + Development Advisory services supporting research and development activities, including regulatory compliance, clinical trial design, and intellectual property strategy for healthcare and life sciences companies.
- Health Policy + System Transformation Consulting on health policy development and healthcare system transformation, helping shape regulatory frameworks and advocating for innovation-friendly policies in Germany and Europe. Includes stakeholder engagement and legislative commentary services.
- Innovative Care Solutions Strategic guidance on innovative care delivery models, including digital health applications (DiGA), telemedicine solutions, and novel healthcare technology integration. Supports clients through BfArM Fast-Track approval and reimbursement pathways.
- Quick Check - Cloud Compliance Advisory
Quantifiable outcome
- Dierks+Company has recruited multiple senior experts from key German healthcare institutions in 2024, indicating strong demand for the firm's expertise and market position.
Companies that use Dierks+Company
Customer profileNamed customers1 record
Segments12 records
Ideal customer profiles5 records
Dierks+Company technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Dierks+Company partnerships and signals
Strategic signalScale indicators2 records
Recent moves7 records
Expansion highlights6 records
Dierks+Company competitors and assessment
Company assessmentBroad incumbents
- PwC (Healthcare): Big 4 firm with healthcare and pharma advisory, compliance, and transformation services across Europe. Comparable as broad-based healthcare management consulting competitor, though with much wider service portfolio.
- Bain & Company (Healthcare): Global strategy consulting firm with strong healthcare and life sciences practice covering pharma, payers, providers, and digital health. Competes on healthcare strategy transformation mandates at the enterprise level.
- Latham & Watkins (Healthcare & Life Sciences): Global law firm with a leading healthcare and life sciences practice advising on regulatory, market access, FDA/EMA matters, and digital health. Comparable for large pharma/device regulatory mandates from the legal side.
- Deloitte (Life Sciences & Healthcare): Global professional services firm with extensive pharma, medtech, payer, and provider advisory. Comparable on healthcare regulatory and strategy consulting at larger scale, though much broader portfolio.
- McKinsey & Company (Healthcare Practice): Global management consulting firm with a large healthcare and life sciences practice serving pharma, medtech, payers, and providers. Compares on healthcare strategy and transformation advisory for large enterprise clients, though it is a broader, non-specialized law/strategy boutique.
- Covington & Burling (Healthcare/Life Sciences): Global law firm renowned for healthcare regulatory, FDA/EMA, market access, and digital health work. Comparable legal advisor for innovative health products, with deeper US footprint but overlapping EU practice.
- Clifford Chance (Healthcare & Life Sciences): Global law firm with a leading healthcare and life sciences practice advising on regulatory, market access, and digital health matters. Comparable legal services competitor for innovative pharma and digital health clients.
Direct peers
- Simon-Kucher & Partners (Pharma & Healthcare): Boutique consultancy with deep pharma, medtech, and healthcare pricing and market access expertise. Closely comparable on healthcare strategy pricing, reimbursement, and market access advisory, particularly in Germany and Europe.
- Taylor Wessing (Healthcare & Life Sciences): European law firm with a dedicated Healthcare & Life Sciences practice advising pharma, medical device, and digital health clients on regulatory, market access, and compliance matters. Directly comparable legal services offering for innovative healthcare companies.
Regional players
- Roland Berger: Germany-headquartered strategy consulting firm with a healthcare practice covering pharma, hospitals, and digital health. Comparable as a German-rooted healthcare strategy consulting competitor with similar client base in DACH.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Dierks+Company social profiles
Digital presenceDierks+Company financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dierks+Company leadership team
Management profileNumber of profiles
Profiles3 records
Dierks+Company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dierks+Company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dierks+Company
What does Dierks+Company do?
Dierks+Company provides legal and strategy consulting services to healthcare and life sciences clients across Germany and Europe. The firm operates across five core practice areas: Health Data, Market Access + HTA, Research + Development, Health Policy + System Transformation, and Innovative Care Solutions. Services are delivered by senior experts combining legal counsel (through Rechtsanwaltsgesellschaft mbH) and strategic consulting (through Consulting GmbH) for pharmaceutical, medical device, IVD, digital health, hospital, payer, and legislative clients.
Is Dierks+Company a public or private company?
Dierks+Company is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dierks+Company founded?
Dierks+Company was founded in 2018. It employs 11 to 50 people.
Where is Dierks+Company based?
Dierks+Company is headquartered in Berlin, Germany, in the Europe region.
How does Dierks+Company make money?
One revenue line is on record: legal and Strategy Consulting Services.
Who are Dierks+Company's main competitors?
Broad incumbents on record are PwC (Healthcare), Bain & Company (Healthcare), Latham & Watkins (Healthcare & Life Sciences), Deloitte (Life Sciences & Healthcare), McKinsey & Company (Healthcare Practice), Covington & Burling (Healthcare/Life Sciences) and Clifford Chance (Healthcare & Life Sciences). Direct peers are Simon-Kucher & Partners (Pharma & Healthcare) and Taylor Wessing (Healthcare & Life Sciences). Roland Berger is listed as a regional player.
Does Dierks+Company have an API?
No public API is recorded for Dierks+Company.